Collect Biospecimens from subjects who are newly diagnosed with Acute Myeloid Leukemia (AML)

This is a clinical research study to learn more about a drug being developed to treat Hidradenitis Suppurativa. We want to learn more about how this study drug affects those with Hidradenitis Suppurativa.

In this study, we want to learn how underrepresented soldiers stay resilient, fit, and healthy.

Do you identify as LGBTQ+ or queer, and have you gone through all or part of a family planning process? Or, do you aid LGBTQ+ individuals in their family planning as part of your work? If so, we are seeking perspectives on these processes and the types of stress and social support experienced during them.

The purpose of this study is to find out whether the addition of HDV to Humalog® will improve diabetes control by reducing high blood sugar after meals and/or reducing the risk of low blood sugar (hypoglycemia) during insulin treatment. The safety and tolerability of Humalog® with or without added HDV will also be evaluated. The study drugs will be administered by subcutaneous (under the skin) injection.

In this study, I want to learn how people who identify as Latino, Hispanic, and/or from Latin America make sense of and understand their identity.

The focus of the research is on the challenges associated with achieving explainability in analytics and AI powered approaches applied in risk predictions in maternal health. As part of this research, we aim to conduct a usability study of an AI-driven postpartum depression risk assessment tool engaging healthcare providers - including doctors, nurses, and midwives - as participants. The usability study will assess healthcare provider's interactions and engagement with the web-based tool, measured by the System Explainability Scale (SES) Score, which quantifies its overarching Explainability, considering the dimensions of understandability, trust, and usability.

The purpose of this research study is to better understand how day-to-day differences in people's public speaking anxiety relate to how well they respond to therapy for public speaking anxiety.

Efgartigimod has been approved by the U.S. FDA (Food and Drug Administration) as a treatment for adult patients with gMG in whom AChR-Ab's are present. However, it was not approved it for the form of gMG that is AChR Ab seronegative (antibodies not present). and therefore this study is now testing how efragtigimod works in patients without any antibodies,

Do you have Hidradenitis Suppurativa (HS)? You may be eligible to participate in a research study assessing the effect of an investigational product in HS and its impact on quality of life. If eligible, and you decide to participate, you will receive the study drug study related medical evaluation and compensation for completed visits.